These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7655394)

  • 1. Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia.
    Shepherd JD; Gascoyne RD; Barnett MJ; Coghlan JD; Phillips GL
    Bone Marrow Transplant; 1995 Apr; 15(4):639-41. PubMed ID: 7655394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
    Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
    Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease.
    Ringhoffer M; Döhner K; Scheil S; Wilts H; Mertens T; Grimminger W; Döhner H; Bunjes D
    Bone Marrow Transplant; 2001 Sep; 28(6):615-8. PubMed ID: 11607777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation.
    Haut PR; Kovarik P; Shaw PH; Walterhouse D; Jenson HB; Kletzel M
    Bone Marrow Transplant; 2001 Apr; 27(7):761-5. PubMed ID: 11360119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
    Pondarré C; Kebaili K; Dijoud F; Basset T; Philippe N; Bertrand Y
    Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease.
    Yufu Y; Kimura M; Kawano R; Noguchi Y; Takatsuki H; Uike N; Ohshima K
    Bone Marrow Transplant; 2000 Dec; 26(12):1339-41. PubMed ID: 11223975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain.
    Nagafuji K; Eto T; Hayashi S; Oshima K; Maeda Y; Gondo H; Inamura T; Niho Y
    Bone Marrow Transplant; 1998 Jun; 21(11):1155-8. PubMed ID: 9645581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR.
    Hamadani M; Martin LK; Benson DM; Copelan EA; Devine SM; Hofmeister CC
    Bone Marrow Transplant; 2007 Feb; 39(4):249-51. PubMed ID: 17290281
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation.
    Aisa Y; Mori T; Nakazato T; Suzuki S; Suzuki N; Ikeda Y; Okamoto S
    Transpl Infect Dis; 2009 Oct; 11(5):438-41. PubMed ID: 19497045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation.
    Jindra P; Koza V; Boudová L; Vozobulová V; Cerná K; Karas M; Lysák D; Svojgrová M
    Bone Marrow Transplant; 2003 May; 31(10):951-2. PubMed ID: 12748677
    [No Abstract]   [Full Text] [Related]  

  • 18. Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorder.
    Khatri VP; Baiocchi RA; Peng R; Oberkircher AR; Dolce JM; Ward PM; Herzig GP; Caligiuri MA
    J Immunol; 1999 Jul; 163(1):500-6. PubMed ID: 10384154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
    Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.